Insider trading · Q3 2026 · CIK 1817229

Vor Biopharma Inc. (VOR) insider trading.

In Q3 2026, insiders at Vor Biopharma Inc. reported 3 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $4K.

Transactions
3
Purchases (P)
0
Sales (S)
1
Net shares, P minus S
-213
Insiders
2
Last filed
2026-08-26

Insiders

Transactions

3 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-24RA Capital Healthcare Fund LP / Kolchinsky Peter / RA CAPITAL MANAGEMENT, L.P. / Shah Rajeev M.M (A)1,500$3.741,500Form 4
2026-07-16Shah Rajeev M. / RA CAPITAL MANAGEMENT, L.P. / Kolchinsky Peter / RA Capital Healthcare Fund LPX (A)2,100,000$04,502,095Form 4
2026-07-16Shah Rajeev M. / RA CAPITAL MANAGEMENT, L.P. / Kolchinsky Peter / RA Capital Healthcare Fund LPS (D)213$19.754,501,882Form 4

Transaction codes in this quarter

Get VOR insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1817229&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · VOR company page · Vor Biopharma Inc. on SEC.gov

Questions

Are insiders buying or selling Vor Biopharma Inc. (VOR)?

In Q3 2026, insiders at Vor Biopharma Inc. reported 3 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $4K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Vor Biopharma Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/vor.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.